<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35569293</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1872-6283</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>336</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>Forensic science international</Title>
          <ISOAbbreviation>Forensic Sci Int</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Drug consumption of suspected drug-influenced drivers in Hungary (2016-2018).</ArticleTitle>
        <Pagination>
          <StartPage>111325</StartPage>
          <MedlinePgn>111325</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.forsciint.2022.111325</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0379-0738(22)00155-4</ELocationID>
        <Abstract>
          <AbstractText>The hazard caused by driving under the influence of drugs (DUID) is determined by the time of consumption, dose and biological effects of a substance, as well as by synergistic drug interactions after multi-drug use. The aim of this work was to investigate the prevalence and pattern of psychoactive substance use of suspected DUID drivers and to present the advantages and disadvantages of the system currently used for determination of impairment in Hungary. Blood and urine samples, collected between 2016 and 2018, were taken from 2369 drivers with a positivity rate of 95% for at least one substance. Classical illicit drugs were detected in 76-87%, prescription medications in 9-15%, stimulant New Psychoactive Substances (sNPS) in 3-8%, and synthetic cannabinoids (SCs) in 20-22% of the positive samples. The most frequent substances according to substance groups were: classical illicit drugs: cannabis (n = 1240), amphetamine and methamphetamine (AM/MA) (n = 753), MDMA (n = 196), and cocaine (n = 180), medicines: alprazolam (n = 188) and clonazepam (n = 83), sNPS: N-ethyl-hexedrone (n = 115), SCs: 5 F-MDMB-PINACA (n = 267), AMB-FUBINACA (n = 92) and ADB-FUBINACA (n = 90). The median age of classical illicit drugs users was 29 years, prescription medicine users were 33 years old, sNPS users were 28 years, and SC users were 26 years old. Compared to the previous two years, we found pronounced changes in the ratio of sNPS (14% decrease) and SC users (10% increase), and in the pattern of NPS consumption. The ratio of multi-drug use varied between 38% and 50%. 69% of drivers tested positive were deemed impaired. Impairment was determined according to impairment limits (80-82%), multi-drug use (12-13%), and the result of medical investigation when a single active substance with no set impairment limit was detected in the blood (6-8%). The results of medical investigations may be uncertain due to the long time delay between arrest and clinical examination and to the structure of medical investigations created for determination of alcoholic impairment. In conclusion, a revision of the current medical investigation protocol is warranted to standardize clinical symptom scores that better correlate with driving impairment.</AbstractText>
          <CopyrightInformation>Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Institóris</LastName>
            <ForeName>László</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Forensic Medicine, Faculty of Medicine, University of Szeged, Szeged, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hidvégi</LastName>
            <ForeName>Előd</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Forensic Toxicology, Hungarian Institute for Forensic Sciences, Budapest, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kovács</LastName>
            <ForeName>Katalin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Forensic Medicine, Faculty of Medicine, University of Szeged, Szeged, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jámbor</LastName>
            <ForeName>Ákos</ForeName>
            <Initials>Á</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Forensic Medicine, Faculty of Medicine, University of Szeged, Szeged, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dobos</LastName>
            <ForeName>Adrienn</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Forensic Toxicology, Hungarian Institute for Forensic Sciences, Budapest, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rárosi</LastName>
            <ForeName>Ferenc</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Physics and Informatics, Faculty of Medicine, University of Szeged, Szeged, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Süvegh</LastName>
            <ForeName>Gábor</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Forensic Toxicology, Hungarian Institute for Forensic Sciences, Budapest, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Varga</LastName>
            <ForeName>Tibor</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Forensic Medicine, Faculty of Medicine, University of Szeged, Szeged, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kereszty</LastName>
            <ForeName>Éva M</ForeName>
            <Initials>ÉM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Forensic Medicine, Faculty of Medicine, University of Szeged, Szeged, Hungary. Electronic address: kereszty.eva.margit@med.u-szeged.hu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Ireland</Country>
        <MedlineTA>Forensic Sci Int</MedlineTA>
        <NlmUniqueID>7902034</NlmUniqueID>
        <ISSNLinking>0379-0738</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Blood concentration and impairment</Keyword>
        <Keyword MajorTopicYN="N">Prevalence of drug consumption</Keyword>
        <Keyword MajorTopicYN="N">Suspected DUID drivers</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>15</Day>
          <Hour>18</Hour>
          <Minute>14</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35569293</ArticleId>
        <ArticleId IdType="doi">10.1016/j.forsciint.2022.111325</ArticleId>
        <ArticleId IdType="pii">S0379-0738(22)00155-4</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
